Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EIDX [NASD]
Eidos Therapeutics, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-2.65 Insider Own1.00% Shs Outstand38.39M Perf Week4.59%
Market Cap4.85B Forward P/E- EPS next Y-3.29 Insider Trans-23.12% Shs Float12.82M Perf Month12.67%
Income-100.80M PEG- EPS next Q-0.81 Inst Own31.00% Short Float3.91% Perf Quarter71.49%
Sales0.10M P/S48478.63 EPS this Y44.60% Inst Trans-3.10% Short Ratio3.15 Perf Half Y160.36%
Book/sh3.20 P/B39.53 EPS next Y-11.90% ROA-53.00% Target Price70.38 Perf Year127.66%
Cash/sh3.84 P/C32.91 EPS next 5Y28.00% ROE-65.20% 52W Range28.39 - 132.54 Perf YTD-3.85%
Dividend- P/FCF- EPS past 5Y- ROI-21.60% 52W High-4.55% Beta-
Dividend %- Quick Ratio11.10 Sales past 5Y- Gross Margin- 52W Low345.61% ATR5.69
Employees70 Current Ratio11.10 Sales Q/Q-99.60% Oper. Margin- RSI (14)61.07 Volatility5.20% 4.55%
OptionableYes Debt/Eq0.14 EPS Q/Q-527.70% Profit Margin- Rel Volume0.56 Prev Close128.51
ShortableYes LT Debt/Eq0.14 Earnings- Payout- Avg Volume159.34K Price126.51
Recom3.20 SMA202.57% SMA5023.80% SMA200101.44% Volume89,215 Change-1.56%
Nov-18-20Downgrade BTIG Research Buy → Neutral
Sep-22-20Downgrade Guggenheim Buy → Neutral
Sep-08-20Initiated Citigroup Buy $80
May-14-20Downgrade JP Morgan Overweight → Neutral $58 → $50
Apr-01-20Resumed BofA/Merrill Neutral $51
Feb-20-20Initiated Guggenheim Buy $66
Feb-18-20Downgrade Barclays Equal Weight → Underweight $45
Nov-01-19Downgrade Barclays Overweight → Equal Weight $37 → $45
Jul-22-19Initiated Piper Jaffray Overweight $55
Feb-27-19Upgrade JP Morgan Neutral → Overweight
Jan-23-19Downgrade JP Morgan Overweight → Neutral
Oct-31-18Initiated ROTH Capital Buy
Jul-16-18Initiated JP Morgan Overweight $36
Jul-16-18Initiated BofA/Merrill Neutral $24
Jul-16-18Initiated Barclays Overweight $32
Jan-13-21 04:30PM  
BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for Merger
GlobeNewswire
Jan-12-21 09:30AM  
SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
ACCESSWIRE
Jan-08-21 08:30PM  
MERGER INVESTIGATION: Halper Sadeh LLP Investigates CPAH, HMSY, SNSS, EIDX; Shareholders Are Encouraged to Contact the Firm
ACCESSWIRE
Jan-06-21 04:54PM  
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, and XLNX Shareholders About Its Ongoing Investigations
PR Newswire
Jan-05-21 11:26AM  
ALERT: Halper Sadeh LLP Investigates ALXN, SPWH, CBMG, STND, EIDX; Shareholders Are Encouraged to Contact the Firm
PR Newswire
Jan-04-21 11:42AM  
EIDOS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EIDX and Encourages Investors to Contact the Firm
GlobeNewswire -10.84%
07:30AM  
Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote FOR Proposed Merger
GlobeNewswire
Jan-03-21 02:20PM  
Lifshitz Law Firm, P.C. Announces Investigation of EIDX, NAV, STND, and WTRE
ACCESSWIRE
Jan-02-21 07:30AM  
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages CKH, PS, WDR, and EIDX Shareholders to Contact the Firm
ACCESSWIRE
Dec-30-20 08:49PM  
WeissLaw LLP Reminds MTSC, EIDX, IPHI, and ALXN Shareholders About Its Ongoing Investigations
PR Newswire
10:04AM  
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers CKH, WDR, NAV, EIDX
GlobeNewswire
Dec-29-20 11:15AM  
EIDX ALERT - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ:EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
Dec-28-20 08:20PM  
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PRGX, STND, NK, EIDX, ARA
PR Newswire
09:15AM  
EIDX ALERT - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
Dec-26-20 01:55PM  
STOCK ALERT: Monteverde & Associates Launches Legal Investigation for the Following Merger
ACCESSWIRE
10:05AM  
Lifshitz Law Firm, P.C. Announces Investigation of EIDX, NAV, STND, and WTRE
ACCESSWIRE
Dec-24-20 10:45AM  
EIDX ALERT Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
09:09AM  
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers STND, EIDX, ARA, RESI
GlobeNewswire
Dec-23-20 09:00PM  
SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
ACCESSWIRE
Dec-19-20 04:17PM  
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIX
PR Newswire
Dec-18-20 10:12PM  
SHAREHOLDER ALERT: WeissLaw LLP Reminds DMYD, EIDX, IPHI, and MCAC Shareholders About Its Ongoing Investigations
PR Newswire
Dec-17-20 11:08PM  
Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, EIDX, CIT, EMIS, FCNCA, FCNCB, EV, MS, NAV, STND, and WTRE
PR Newswire
Dec-16-20 01:14PM  
STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
PR Newswire
10:10AM  
EIDX ALERT - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
Dec-14-20 08:42PM  
Is EIDX A Good Stock To Buy Now?
Insider Monkey
09:10AM  
Eidos Reportedly Received $4.6 Billion Takeover Bid From Glaxo
TheStreet.com
Dec-12-20 09:12AM  
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm CBMG, MVC, STND, EIDX
GlobeNewswire
Dec-11-20 09:13PM  
Glaxo Bids $120 a Share for Eidos in Rival Offer
Bloomberg +6.86%
08:52PM  
WeissLaw LLP Reminds EIDX, IPHI, TGC, and APXT Shareholders About Its Ongoing Investigations
PR Newswire
Dec-05-20 05:06AM  
ALERT: Halper Sadeh LLP Encourages EIDX, WTRE, RESI, and XLNX Shareholders to Contact the Firm
GlobeNewswire
Dec-04-20 08:51PM  
WeissLaw LLP Reminds IPHI, EMIS, and EIDX Shareholders About Its Ongoing Investigations
PR Newswire
08:00PM  
STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
ACCESSWIRE
11:48AM  
INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - PNM, ELY, TNAV, NAV, EIDX
PR Newswire
Dec-02-20 12:03PM  
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MCEP, EIDX, CCR, and TGC Mergers
GlobeNewswire
Nov-25-20 10:32PM  
Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm STND, EIDX, WTRE, EV
GlobeNewswire
08:01AM  
Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, BMCH, BLDR, CIT, EV, EIDX, NAV, STND and WTRE
PR Newswire
Nov-23-20 08:31PM  
WeissLaw LLP Reminds PTI, MVC, and EIDX Shareholders About Its Ongoing Investigations
PR Newswire
Nov-20-20 09:34PM  
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm GLIBA, EIDX, EV, PNM
GlobeNewswire
08:30PM  
SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
ACCESSWIRE
Nov-19-20 06:36PM  
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, CEIX, PNM, and EIDX Mergers
GlobeNewswire
Nov-13-20 10:35PM  
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm STND, EIDX, WTRE, EV
GlobeNewswire
08:00PM  
STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
ACCESSWIRE
07:01PM  
SHAREHOLDER ALERT: WeissLaw LLP Reminds MVC, MOBL, GMHI, and EIDX Shareholders About Its Ongoing Investigations
PR Newswire
12:30PM  
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IPHI, EIDX, CEIX, and PNM Mergers
GlobeNewswire
08:01AM  
Lifshitz Law Firm, P.C. Announces Investigation of CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited
ACCESSWIRE
Nov-12-20 01:40PM  
INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - GLIBA, VRTU, PRCP, WPX, EIDX
PR Newswire +5.10%
Nov-09-20 06:15PM  
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigation of Eidos Therapeutics, Inc. Buyout
PR Newswire
Nov-07-20 07:49PM  
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm EIDX, WTRE, ARA, CIT
GlobeNewswire
Nov-06-20 11:27PM  
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, GLIBA, and EV Shareholders About Its Ongoing Investigations
PR Newswire
08:00PM  
STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
ACCESSWIRE
08:01AM  
Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited
PR Newswire
Nov-05-20 10:53AM  
New Strong Sell Stocks for November 5th
Zacks
07:30AM  
BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update
GlobeNewswire
Nov-03-20 10:39AM  
New Strong Sell Stocks for November 3rd
Zacks
Oct-31-20 06:57PM  
ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - EIDX, RESI, PE, ARA
PR Newswire
Oct-30-20 09:41PM  
SHAREHOLDER ALERT: WeissLaw LLP Reminds VRTU, GLIBA, EV and EIDX Shareholders About Its Ongoing Investigations
PR Newswire
03:31PM  
Lifshitz Law Firm, P.C. Announces Investigation of Callaway Golf Company (NYSE: ELY), Eidos Therapeutics, Inc. (NASDAQ: EIDX), Inphi Corporation (NASDAQ: IPHI), and Watford Holdings Ltd. (NASDAQ:WTRE)
GlobeNewswire
Oct-29-20 04:30PM  
Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update
GlobeNewswire
Oct-27-20 10:15AM  
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm GLIBA, CBMG, YIN, EIDX
ACCESSWIRE
Oct-26-20 06:54PM  
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Eidos Therapeutics, Inc. (NASDAQ:EIDX), BioSpecifics Technologies Corp. (NASDAQ:BSTC), Front Yard Residential Corporation (NYSE:RESI)
ACCESSWIRE
01:37PM  
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, BSTC, CIT, and EIDX Mergers
GlobeNewswire
Oct-24-20 02:10PM  
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm STND, MYOK, EIDX, WTRE
ACCESSWIRE
Oct-23-20 04:44PM  
Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited
PR Newswire
Oct-22-20 08:37PM  
SHAREHOLDER ALERT: WeissLaw LLP Reminds MYOK, EIDX, GLIBA, and EV Shareholders About Its Ongoing Investigations
PR Newswire
07:17PM  
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Eidos Therapeutics, Inc. (NASDAQ:EIDX), BioSpecifics Technologies Corp. (NASDAQ:BSTC), Front Yard Residential Corporation (NYSE:RESI)
ACCESSWIRE
05:00PM  
SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
ACCESSWIRE
Oct-21-20 10:20PM  
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm - MYOK, EIDX, CBMG, CXO
ACCESSWIRE
06:48PM  
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Eidos Therapeutics, Inc. (Nasdaq - EIDX), BioSpecifics Technologies Corp. (NasdaqGS - BSTC), Front Yard Residential Corporation (NYSE - RESI)
ACCESSWIRE
08:25AM  
ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm - EIDX, EV
ACCESSWIRE
Oct-20-20 06:00PM  
STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
ACCESSWIRE
03:12PM  
SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm - MYOK, EIDX, CBMG
PR Newswire
10:00AM  
EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
Oct-19-20 03:24PM  
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers
GlobeNewswire
09:10AM  
EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
Oct-17-20 02:05PM  
INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm MYOK, EIDX, WTRE, EV
ACCESSWIRE
Oct-15-20 04:23PM  
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, REXN, and WPX Shareholders About Its Ongoing Investigations
PR Newswire
12:07PM  
Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Cellular Biomedicine Group, Inc., and Eidos Therapeutics, Inc.
GlobeNewswire
10:45AM  
EIDX INVESTIGATION Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
Oct-14-20 07:00PM  
SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm WPX, STND, EIDX, EV
ACCESSWIRE
06:52PM  
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: AMAG Pharmaceuticals, Inc. (Nasdaq-AMAG), MyoKardia, Inc. (Nasdaq - MYOK), Eidos Therapeutics, Inc. (Nasdaq - EIDX)
ACCESSWIRE
03:09PM  
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Eidos Therapeutics, Inc. -EIDX
PR Newswire
01:14PM  
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers
GlobeNewswire
09:45AM  
EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
Oct-13-20 08:20PM  
ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm MYOK, EIDX, WTRE, ARA
ACCESSWIRE
12:40PM  
EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
08:03AM  
EIDX INVESTOR ALERT - Andrews & Springer LLC Is Investigating Eidos Therapeutics, Inc. For Potential Breaches of Fiduciary Duty
ACCESSWIRE
Oct-12-20 07:40PM  
INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Eidos Therapeutics, Inc. (EIDX) and Encourages Investors to Contact the Firm
ACCESSWIRE
09:15AM  
EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
08:00AM  
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Investors are Encouraged to Contact the Firm - MYOK, EIDX, GLIBA, MR
ACCESSWIRE
Oct-09-20 06:23PM  
EIDOS MERGER INVESTIGTION ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Eidos Therapeutics, Inc. - EIDX
GlobeNewswire
02:38PM  
EIDOS THERAPEUTICS INVESTOR ALERT BY The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eidos Therapeutics, Inc. - EIDX
Business Wire
11:19AM  
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, GLIBA, SUNW, and BMCH Mergers
GlobeNewswire
09:00AM  
EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
08:01AM  
Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited
PR Newswire
Oct-08-20 04:00PM  
EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ:EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
09:00AM  
EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ:EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
ACCESSWIRE
Oct-07-20 08:05PM  
INVESTIGATION UPDATE: Kaskela Law LLC Announces Stockholder Investigation of Eidos Therapeutics, Inc. (EIDX) and Encourages EIDX Shareholders to Contact the Firm
ACCESSWIRE
06:30PM  
SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm MYOK, EIDX, GLIBA, GRUB
ACCESSWIRE
05:36PM  
EIDX INVESTIGATION Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
Business Wire
10:10AM  
EIDOS THERAPEUTICS (EIDX) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Eidos Therapeutics, Inc.
ACCESSWIRE
Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs to treat diseases caused by transthyretin (TTR) or amyloidosis (ATTR). It is developing AG10, which is in phase 3 clinical trial, is an orally-administered small molecule designed to stabilize tetrameric TTR, thereby halting at its outset the series of molecular events that give rise to ATTR. The company was founded in 2013 and is headquartered in San Francisco, California. Eidos Therapeutics, Inc. is a subsidiary of BridgeBio Pharma, Inc.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sinha UmaChief Scientific OfficerJan 13Sale124.3210,0001,243,179306,525Jan 15 04:05 PM
Valle FrancoSenior Vice President, FinanceJan 12Option Exercise7.241,74712,6481,747Jan 13 04:05 PM
Valle FrancoSenior Vice President, FinanceJan 12Sale125.451,747219,1520Jan 13 04:05 PM
Valle FrancoSenior Vice President, FinanceJan 11Option Exercise7.241,50010,8601,500Jan 13 04:05 PM
Valle FrancoSenior Vice President, FinanceJan 11Sale125.611,500188,4080Jan 13 04:05 PM
Turtle CameronChief Business OfficerDec 15Option Exercise13.8426,294363,99576,915Dec 16 07:27 PM
Turtle CameronChief Business OfficerDec 15Sale111.7726,2942,938,79650,621Dec 16 07:27 PM
Sinha UmaChief Scientific OfficerDec 02Sale90.045,000450,187316,525Dec 04 05:34 PM
Turtle CameronChief Business OfficerNov 11Sale74.5113,410999,22752,121Nov 13 05:00 PM
Valle FrancoSenior Vice President, FinanceNov 09Option Exercise7.241,62311,7511,623Nov 10 04:05 PM
Valle FrancoSenior Vice President, FinanceNov 09Sale74.931,623121,6090Nov 10 04:05 PM
Turtle CameronChief Business OfficerNov 02Option Exercise14.477,500108,50078,031Nov 03 04:05 PM
Turtle CameronChief Business OfficerNov 02Sale70.7212,500883,95465,531Nov 03 04:05 PM
Sinha UmaChief Scientific OfficerOct 29Sale72.425,000362,099321,525Oct 30 04:55 PM
Valle FrancoSenior Vice President, FinanceOct 08Option Exercise7.245,19937,6415,199Oct 09 05:23 PM
Valle FrancoSenior Vice President, FinanceOct 08Sale74.855,199389,1510Oct 09 05:23 PM
Valle FrancoSenior Vice President, FinanceOct 07Option Exercise7.245,00036,2005,444Oct 09 05:23 PM
Valle FrancoSenior Vice President, FinanceOct 07Sale75.085,444408,7480Oct 09 05:23 PM
Sinha UmaChief Scientific OfficerOct 01Sale52.354,831252,923326,525Oct 02 07:43 PM
Sinha UmaChief Scientific OfficerSep 30Sale52.031698,794331,356Oct 02 07:43 PM
Fox Jonathan CSee RemarksSep 17Sale50.165,767289,259377,673Sep 18 04:06 PM
Fox Jonathan CSee RemarksSep 16Sale50.163,122156,610383,440Sep 16 06:35 PM
Fox Jonathan CSee RemarksSep 15Sale50.061,00050,064386,562Sep 16 06:35 PM
Fox Jonathan CSee RemarksSep 14Sale50.001115,550387,562Sep 16 06:35 PM
Turtle CameronChief Business OfficerSep 10Option Exercise17.002,50042,50073,031Sep 11 04:05 PM
Turtle CameronChief Business OfficerSep 10Sale47.002,500117,50070,531Sep 11 04:05 PM
Turtle CameronChief Business OfficerAug 03Option Exercise13.205,00066,00080,531Aug 05 07:45 PM
Turtle CameronChief Business OfficerAug 03Sale39.9410,000399,45070,531Aug 05 07:45 PM
Fox Jonathan CSee RemarksJul 07Sale50.005,000250,000387,673Jul 09 04:05 PM
open in yahoo | open in reuters | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.